Skip to Content
Search Menu

SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer

Hear Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, presents the updated results of treatment with trastuzumab deruxtecan in patients with HER2 positive metastatic breast cancer.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Related

Anders Winther Mølby Nielsen

New Data Support Boost in ER-/HER2- Breast Cancer

/ Anders W. Mølby Nielsen
Breast cancerNBCN Play the Video 08:40
Birgitte Offersen

Unexpected Mortality in Hypofractionated Loco-Regional Breast Cancer Radiotherapy

/ Birgitte Vrou Offersen
Breast cancerNBCN Play the Video 17:50
Christoffer Vannas

Swedish Insights Into Alpelisib Treatment for Metastatic Breast Cancer with PIK3CA Mutation

/ Christoffer Vannas
Breast cancerNBCN Play the Video 01:52
Malene Grubbe Hildebrandt

The Fascinating World of Using Molecular Imaging in Primary and Metastatic Breast Cancer

/ Malene Grubbe Hildebrandt
Breast cancerNBCN Play the Video 03:45

New Finnish Study Investigates Outcomes of Repeated Breast Conserving Surgery and Radiotherapy

/ Anselm Tamminen
Breast cancerNBCN Play the Video 00:41
Sara Tolaney

ASCO 2025: Redefining First-Line Therapy in HER2+ Breast Cancer with T-DXd and Pertuzumab

/ Sara Tolaney
ASCO25Breast cancerNBCN Play the Video 03:51
Ioannis Zerdes

Multidimensional Profiling of Immune Micro- and Macro-Environment in Early Breast Cancer Treated with Neoadjuvant Therapy

/ Ioannis Zerdes
Breast cancerNBCN Play the Video 01:25
Irma Frederiksson & Tove Filtenborg Tvedskov

Clinical Controversies in Axillary Management in Breast Cancer

/ Irma Frederiksson / Tove Holst Filtenborg Tvedskov
Breast cancerNBCN Play the Video 05:30
Tobias Berg

Increased Need for Improvement in the Treatment of Non-Luminal A Subtype Metastatic Breast Cancer in First-Line Treatment

/ Tobias Berg
Breast cancerNBCN Play the Video 06:01
Back to top